When was PulseAI founded?

PulseAI was founded in 2019 and raised its 1st funding round 7 years after it was founded.

Where is PulseAI located?

PulseAI is headquartered in Belfast, United Kingdom.

How many employees does PulseAI have?

As of Sep 30, 2026, the latest employee count at PulseAI is 11.

Is PulseAI a funded company?

PulseAI is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 12, 2026.

When was the latest funding round of PulseAI?

PulseAI's latest funding was a $***** Seed round on Jan 12, 2026, with participation from 2 investors.

Where does PulseAI rank among its competitors?

PulseAI ranks 5th amongst 62 active competitors, of which 9 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was PulseAI, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of PulseAI?

PulseAI's top competitors include Artrya, VerAvanti and Saigeware Technologies. Among them, PulseAI secured the most recent funding round in January, 2026.

PulseAI - 2026 Company Profile, Funding & Competitors

PulseAI is a seed company based in Belfast (United Kingdom), founded in 2019. It operates as an AI-based heart screening tool for diagnosis. PulseAI has raised an undisclosed amount in funding. The company has 62 active competitors, including 9 funded and 2 that have exited. Its top competitors include companies like Artrya, VerAvanti and Saigeware Technologies.

Key Metrics

Founded Year

2019

Location

Belfast, United Kingdom

Stage

Seed

Latest Funding Round

Seed, Jan 12, 2026, $*****

Investors

Crick & 1 more

Ranked

5^th among 62 active competitors

Employee Count

11 as on Sep 30, 2026

Similar Companies

OpenEvidence & 2943 more

View PulseAI's full profile

PulseAI has raised funding over 1 round. Its latest funding round was a Seed round on Jan 12, 2026 for $*****. 2 investors participated in its latest round. PulseAI has 2 institutional investors.

Here is the list of recent funding rounds of PulseAI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 12, 2026	3918858	Seed	3726450	7815748	4518139	7563339

Access funding benchmarks and valuations. Sign up today!

View details of PulseAI's funding rounds and investors

PulseAI's employee count trend

PulseAI has 11 employees as of Sep 26. Here is PulseAI's employee count trend over the years:

Uncover PulseAI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PulseAI include Artrya, VerAvanti and Saigeware Technologies. Here is the list of Top 10 competitors of PulseAI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Artrya 2018, Perth (Australia), Public	AI-based cardiovascular health analysis tool for providers	-	Alium Capital, NorthStar Impact	51/100
2nd	VerAvanti 2012, Redmond (United States), Series B	Innovating intravascular imaging with advanced single-use endoscopes for enhanced patient care	$38.9M	HHS	45/100
3rd	Saigeware Technologies 2019, Bengaluru (India), Seed	AI-based decision support tool for cardiac and pulmonary practices	$256K	Ideaspring Capital, SFAL & 4 others	45/100
4th	egnite 2021, Aliso Viejo (United States), Unfunded	AI-based cardiac health data analysis software for decision support	-	-	41/100
5th	PulseAI 2019, Belfast (United Kingdom), Seed	AI-based heart screening tool for diagnosis	-	Crick, Ulster University	41/100
6th	Waferchips Techno Solutions 2015, Kollam (India), Seed	Provider of platform for patients with early cardiac symptoms	$117K	CCMB, Kickstartup Advisory Services & 2 others	40/100
7th	PrediSurge 2017, Saint Etienne (France), Series A	Provider of decision making tools for cardiologists	$8.51M	Europa, LIFTT & 2 others	39/100
8th	Pie Medical Imaging 1995, Maastricht (Netherlands), Unfunded	Software solutions for medical diagnostics and interventions	-	-	36/100
9th	Qianglian Zhichuang 2016, Beijing (China), Series D	Developer of AI-driven solutions for cerebrovascular disease diagnosis and treatment	-	Sequoia Capital, Sunland Fund & 4 others	33/100
10th	x-cardiac 2019, Berlin (Germany), Seed	AI-based cardiac health diagnosis tool for healthcare professionals	-	IBB Ventures, IBB & 7 others	33/100